Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ascendis Pharma A/S - American Depositary Shares
(NQ:
ASND
)
153.96
+1.65 (+1.08%)
Streaming Delayed Price
Updated: 10:56 AM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ascendis Pharma A/S - American Depositary Shares
< Previous
1
2
3
4
5
6
7
Next >
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Ascendis Pharma Investors to Inquire About Securities Class Action Investigation - ASND
April 14, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
April 12, 2023
Via
Benzinga
ASCENDIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ascendis Pharma A/S on Behalf of Ascendis Stockholders and Encourages Investors to Contact the Firm
April 07, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Why Ascendis Pharma Stock Is Crashing This Week
April 06, 2023
The FDA put a roadblock in the path to market for Ascendis' hypoparathyroidism drug.
Via
The Motley Fool
Analyst Ratings for Ascendis Pharma
April 03, 2023
Via
Benzinga
Why Ascendis Pharma Stock Is Plunging Today
April 03, 2023
A regulatory hiccup is weighing on the biopharma's shares today.
Via
The Motley Fool
Ascendis Pharma Flags Regulatory Delay In US For Its Hypoparathyroidism Candidate
April 03, 2023
Via
Benzinga
Earnings Scheduled For February 16, 2023
February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2023
April 05, 2023
Via
Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ascendis Pharma A/S (ASND) Investigation
April 04, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ascendis Pharma A/S and Encourages Investors with Losses to Contact the Firm
April 04, 2023
From
The Schall Law Firm
Via
Business Wire
Analyst Expectations for Ascendis Pharma's Future
February 03, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
April 04, 2023
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ascendis Pharma A/S and Encourages Investors with Losses to Contact the Firm
April 03, 2023
From
The Schall Law Firm
Via
Business Wire
Where Ascendis Pharma Stands With Analysts
November 29, 2022
Via
Benzinga
What 9 Analyst Ratings Have To Say About Ascendis Pharma
November 29, 2022
Via
Benzinga
Analyst Ratings for Ascendis Pharma
November 29, 2022
Via
Benzinga
Nasdaq Down 80 Points; VirTra Shares Spike Higher
April 03, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 80 points on Monday. The Dow traded up 0.89% to 33,571.43 while the NASDAQ fell 0.66% to 12,142.07. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 03, 2023
Via
Benzinga
Dow Up Triple Digits As Second Quarter Kicks Off
April 03, 2023
The Dow Jones Industrial Average is up 146 points midday to kick off the second quarter, while the S&P 500 Index inches lower, and the Nasdaq Composite sits firmly in the red.
Via
Talk Markets
Crude Oil Jumps Over 6%; OncoSec Medical Shares Plummet
April 03, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday. The Dow traded up 0.58% to 33,468.38 while the NASDAQ fell 0.96% to 12,104.67. The...
Via
Benzinga
Tesla, NIO And Other Big Stocks Moving Lower On Monday
April 03, 2023
U.S. stocks traded mixed, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 03, 2023
Gainers Nogin, Inc. (NASDAQ: NOGN) shares surged 172.4% to $7.41. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 101% to $14.24 after climbing 50% on Friday.
Via
Benzinga
Ascendis Stock Plunges As FDA Identifies Deficiencies In Company's New Drug Application
April 03, 2023
The FDA decision prevents Ascendis from labeling and marketing the new drug application for TransCon PTH. ASND stock plunged
Via
Investor's Business Daily
ASND LOSS ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Ascendis Pharma Investors to Inquire About Securities Class Action Investigation – ASND
April 03, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 03, 2023
Via
Benzinga
BridgeBio Soars 64% And Breaks Out After Smashing Expectations In A Dwarfism Study
March 06, 2023
The company is testing a drug for children with achondroplasia, a cause of dwarfism.
Via
Investor's Business Daily
Johnson & Johnson: Taking The Bull By The Horns?
February 21, 2023
Johnson & Johnson is rushing toward a patent cliff but a new shelf offering registration suggests itis gearing up for acquisitions.
Via
MarketBeat
Topics
Intellectual Property
Regulatory Compliance
Exposures
Intellectual Property
Legal
Regulatory
Week In Review: Qitan Raises $101 Million For Nanopore Sequencing Devices
January 14, 2023
Qitan Technology, a Chengdu nanopore sequencing company, completed a $101 million Series C round to support its commercialized nanopore devices. Meanwhile, Japan’s Takeda was approved to launch...
Via
Talk Markets
Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday
November 15, 2022
Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.